Monday, 1 April 2019

Novartis pays $310 million upfront for inflammation specialist IFM

Novartis on Monday said it had agreed to pay $310 million upfront, with the possibility for more later, for some assets of Boston-based inflammation specialist IFM Therapeutics as the Swiss drugmaker seeks to expand its immunology pipeline.


from Reuters: Business News https://ift.tt/2HR4ibc

No comments:

Post a Comment

Mark Zuckerberg unveils his latest persona: Elon Musk

Toby Melville/Pool Photo via AP; BRENDAN SMIALOWSKI/AFP via Getty Images; Chelsea Jia Feng/BI While Mark Zuckerberg and Elon Musk nev...